Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
August-2026 Volume 25 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2026 Volume 25 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.pdf
    • Supplementary_Data2.pdf
Article Open Access

Association between tidal volume and mortality in patients without acute respiratory distress syndrome: A systematic review and meta‑analysis

  • Authors:
    • Mingyuan Gu
    • Feiping Xia
    • Zhonghua Lu
    • Shanshan Meng
    • Fengmei Guo
  • View Affiliations / Copyright

    Affiliations: Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, P.R. China
    Copyright: © Gu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
  • Article Number: 98
    |
    Published online on: June 23, 2026
       https://doi.org/10.3892/br.2026.2171
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

The optimal tidal volume for mechanically ventilated patients without acute respiratory distress syndrome (ARDS) remains unclear. The present systematic review and meta‑analysis compared the effects of low compared with high tidal volume (Vt) ventilation in non‑ARDS patients. Randomized controlled trials and observational studies comparing low and high Vt in adults without ARDS were included. The primary outcome was short‑term mortality (28‑ or 30‑day mortality in the ICU or hospital). Secondary outcomes were days of ventilation, pulmonary complications and length of hospital stay. Summary odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a random‑effects model. In total, 18 studies were included (1,530 low Vt vs. 1,512 high Vt patients). No significant difference in short term mortality was observed between low and high Vt ventilation (n=12; OR, 0.88; 95% CI, 0.71‑1.09; P=0.24). However, subgroup analysis by maximum airway pressure (Pmax) showed that low Vt with low Pmax significantly reduced short‑term mortality compared with low Vt with Pmax (OR, 0.50; 95% CI, 0.34‑0.75; P=0.0007). Low Vt also decreased days of ventilation [mean difference (MD), ‑1.00; 95% CI, ‑1.76‑‑0.24; P=0.01], pulmonary complications (n=11 studies; OR, 0.40; 95% CI, 0.30‑0.54; P<0.00001) and hospital stay (n=11 studies; MD, ‑1.49; 95% CI, ‑2.54‑‑0.44; P=0.006). Trial sequential analysis indicated conclusive evidence, suggesting further trials are unlikely to change the conclusion. In conclusion, low Vt combined with low Pmax, but not low Vt alone, improved short‑term mortality in non‑ARDS patients with respiratory failure. Clinically, this suggests that limiting both tidal volume and airway pressure may offer a protective ventilation strategy for non‑ARDS patients, potentially guiding bedside titration of ventilatory settings to reduce mortality. The present study was registered in PROSPERO (https://www.crd.york.ac.uk/PROSPERO/view/CRD42019119453).

Introduction

Mechanical ventilation is the standard treatment for patients with acute respiratory distress syndrome (ARDS). However, a high tidal volume (Vt) may overstretch alveoli, cause ventilator-associated lung injury (1) and increase mortality (2), partly through proinflammatory mediator release induced by biotrauma and volutrauma (3). In ARDS patients, lung-protective ventilation with low Vt has been firmly established as the standard of care based on landmark trials.

By contrast, the protective effect of low Vt ventilation in patients who received mechanical ventilation but do not have ARDS remains controversial. Driving pressure (∆P) is also important for the optimization of mechanical ventilation parameters. Unlike the well-defined benefits in ARDS, the optimal Vt strategy in non-ARDS patients is less clear, as these patients have relatively healthy lungs and may be more tolerant of higher Vt, but are also potentially at risk of developing ventilator-induced lung injury. Certain studies have reported increased morbidity and mortality with high Vt in non-ARDS patients (4,5) and meta-analyses have demonstrated reduced mortality, ventilation duration (6) and pulmonary complications (7) with low Vt in non-ARDS patients. Conversely, a previous randomized control trial (RCT) reported no mortality or ventilation benefit of low Vt compared with that of intermediate Vt in patients without ARDS (8). These conflicting findings highlight a knowledge gap that may require large RCTs to resolve (9).

To address this gap, the present study performed a meta-analysis evaluating low compared with high Vt in patients without ARDS. As outcomes are also influenced by positive endexpiratory pressure (PEEP) (10), ΔP (11) and maximum airway pressure (Pmax) (12), subgroup analyses stratified by these parameters were performed. Additionally, trial sequential analysis (TSA) was applied to assess the robustness and conclusiveness of the evidence. Thus, the present study not only compared low vs. high Vt in non-ARDS patients, but also explored whether confounding factors such as Pmax, PEEP and ΔP modified the relationship between Vt and clinical outcomes, providing a more comprehensive evidence base for bedside ventilation management.

Materials and methods

Study design and registration

The present systematic review and meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines (13) and the recommendations of the Meta-analysis of Observational Studies in Epidemiology Group (14).

Data sources and search strategies

The PubMed, Cochrane Library and EMBASE databases were searched from inception to February 2025 using the following Medical Subject Headings and keywords (‘low Vt’ OR ‘protective ventilation’ OR ‘lower Vt’). No limits were applied for language. The reference lists of eligible studies were also searched to identify additional relevant articles.

Inclusion and exclusion criteria

The inclusion criteria were as follows: i) RCTs or observational studies that reported Vt; ii) patients without ARDS at the start of ventilation (patients without ARDS were defined as mechanically ventilated adults who did not meet the Berlin definition criteria for ARDS (15), consistent with the inclusion criteria of the major trials included in this meta-analysis) (8); and iii) adult patients (aged ≥18 years) undergoing uninterrupted ventilation. The exclusion criteria were as follows: i) Patients who underwent one-lung ventilation; ii) patients with ARDS at the start of ventilation; and iii) reviews, letters, abstracts or editorials. RCTs and observational studies were both included as observational studies can provide real-world evidence and larger sample sizes when RCTs are limited; a sensitivity analysis was employed to assess the effect of including observational studies on the overall findings.

Study selection

A total of two reviewers (MG and FX) independently assessed titles and abstracts to select eligible studies. Full text records were retrieved and reviewed to determine study eligibility. Reviewers were blinded to authors' names, year of publication and journal. Disagreements regarding study selection were resolved by discussion and consensus.

Data extraction and study endpoints

The reviewers independently extracted data from eligible studies, including the author, sample size, study design, patient history of chronic pulmonary disease, study limitations and outcome measures.

The primary outcome was short-term mortality, defined as 28- or 30-day mortality in the intensive care unit (ICU) or hospital. Secondary outcomes were the number of days of ventilation, incidence of pulmonary complications and length of hospital stay.

Assessment of the quality of evidence in included studies

The reviewers independently assessed the methodological quality and risk of bias of each included study. RCTs were assessed using the Cochrane risk of bias tool (16), cohort studies were assessed using the Newcastle-Ottawa scale and cross-sectional studies were assessed using the Agency for Healthcare Research and Quality methodology checklist (17,18). The presence of publication bias was evaluated by visual inspection of funnel plots (19). The strength of evidence was determined using GRADE (20). Disagreements regarding quality of evidence were resolved by discussion and consensus.

Data synthesis and statistical analysis

Statistical analysis was performed using RevMan (v. 5.3; The Cochrane Collaboration) and STATA (v. 12.0; StataCorp LP) software. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were calculated using the inverse-variance weighted approach. Heterogeneity between studies was assessed using the I2 statistic (I2 ≥50% indicating substantial heterogeneity).

Low Vt was defined as <8 ml/kg predicted body weight, and high Vt was defined as >9 ml/kg of predicted body weight. The effects of PEEP, ∆P and Pmax were assessed as confounding factors. The subgroup analysis stratified by Pmax was prespecified in the PROSPERO registration (registration no. CRD42019119453). The following subgroup analyses were predefined: Stratification by PEEP, ΔP and Pmax, based on their known influence on outcomes in mechanically ventilated patients. Specifically, Pmax was categorized as low (≤25 cmH2O) or high (>25 cmH2O) based on previously published thresholds (6,7). Pmax was defined as peak airway pressure in pressure assist-control ventilation and plateau pressure in volume assist-control ventilation. Although peak pressure and plateau pressure are physiologically distinct, both are indicators of Pmax exposure, and limited primary studies reported both values separately. Furthermore, in pressure-controlled ventilation modes commonly used in intraoperative settings, peak pressure approximates plateau pressure in the absence of significant airway resistance (4,10). Given the exploratory nature of this subgroup analysis, studies were pooled using either definition while acknowledging this as a limitation. Data describing PEEP, ∆P and Pmax were extracted, when available. A meta-regression analysis was performed to evaluate the associations between low vs. high Vt and PEEP, ∆P and Pmax. Subgroup analysis was stratified by low Vt and low compared with high Pmax. TSA was applied to control the risk of type I and type II errors due to sparse data and repeated significance testing. TSA calculated the required information size and monitored whether the cumulative evidence crossed the monitoring boundaries, thereby assessing the conclusiveness of the findings (21). P<0.05 was considered to indicate a statistically significant difference.

Results

Study characteristics

The searches identified 6,725 citations, and the full text articles of 79 studies were reviewed. Finally, 18 studies (8,22-38), comprising 2 observational studies (23,37) and 16 RCTs, were included in the meta-analysis (Fig. 1). The characteristics of the included studies are presented in Table I. A total of 3,042 adult patients [low Vt, 1,530 (50.3%); high Vt, 1,512 (49.7%)] were included in the analyses. Of these, 11 studies were ICU-based and 7 were intraoperative; the mixture of these two settings may have increased clinical heterogeneity and this represents a limitation of the meta-analysis. The two settings were included as they represent the two main populations of mechanically ventilated patients without ARDS, and inclusion was restricted to those meeting the same eligibility criteria. Although the mixture of ICU and intraoperative studies may introduce clinical heterogeneity, consistent inclusion and exclusion criteria were applied across both settings to maximize patient homogeneity. Moreover, subgroup analyses and meta-regression were performed to explore potential sources of heterogeneity.

Preferred reporting items for
systematic reviews and meta-analyses flow diagram of study
selection.

Figure 1

Preferred reporting items for systematic reviews and meta-analyses flow diagram of study selection.

Table I

Characteristics of the included studies.

Table I

Characteristics of the included studies.

  Low VtHigh Vt 
First author/s, yearNo.Cause of ventilationPEEP (cmH2O)ΔP (cmH2O)Pmax (cmH2O)PEEP (cmH2O)ΔP (cmH2O)Pmax (cmH2O)Main outcome(Refs.)
Determann et al, 2010150ICU patients7--7--Cytokine levels in BLF and plasma(22)
Fernandez-Bustamante et al, 2011429Abdominal surgery7-20.97-23.6Tidal volume setting(23)
Futier et al, 2013400Abdominal surgery6-89.215.2016.616.1Pulmonary and extrapulmonary complications(24)
Ge et al, 201360Spinal fusion10--7--Pulmonary Complication(25)
Kuzkov et al, 201640Pancreatoduodenal surgery44.612.045.416.4Oxygenation and the incidence of atelectases(26)
Lee et al, 1990103Surgery7-28.97-38.8The incidence of pulmonary infection(27)
Park et al, 201640Laparoscopic surgery5--0--Pulmonary complications(28)
Pi et al, 201563Abdominal surgery96.712.0010.916.4 PaO2/FiO2 ratio and pulmonary compliance(29)
Pinheiro de Oliveira et al, 201020Scheduled surgery512.217.9524.329.8Pulmonary inflammation(30)
Severgnini et al, 201353Abdominal surgery108.7-016.0-Pulmonary Infection Score(31)
Shen et al, 2015120Surgery6--0--Pulmonary compliance(32)
Simonis et al, 2018961ICU patients711.2-713.0-Ventilator-free days(8)
Soh et al, 201878Spinal surgery69.516.4015.216.3Pulmonary complications(33)
Sundar et al, 2011149Cardiac surgery5-613.9-5-615.2-Time to extubation.(34)
Treschan et al, 2012101Abdominal surgery5-15.05-17.0Lung function(35)
Weingarten et al, 201040Abdominal surgery12-14.60-16.8Oxygenation, respiratory system mechanics(36)
Yilmaz et al, 2007375ICU patients5-25.05-30.9The frequency of acute lung injury(37)
Zamani et al, 201761CABG surgery10--0--Postoperative pulmonary complications(38)

[i] Vt, tidal volume (ml/kg predicted body weight); CABG, coronary artery bypass grafting; BLF, bronchoalveolar lavage fluid; ∆P, driving pressure; Pmax, maximum airway pressure.

The risk of bias assessment for RCTs is presented in Fig. S1. Among the 16 RCTs, nine trials were assessed as high risk of performance bias and detection bias (8,25-29,32,34,37) and two trials were assessed as unclear risk of performance bias and detection bias as the authors considered that the outcomes were not influenced by a lack of blinding or that blinding of participants was impossible (30,31). Trials were assessed as low risk of all other biases. The high risk of bias in these nine trials may influence the reliability of the findings; however, these trials represent the best available evidence given the inherent challenge of blinding ventilator settings. Future trials with blinded outcome assessment are warranted to confirm these results. The cohort study (37) scored nine stars (Table SI) and the cross-sectional study (23) scored seven (Table SII) according to Newcastle-Ottawa scale and Agency for Healthcare Research and Quality methodology checklist separately (17,18).

Low Vt ventilation does not decrease short-term mortality in patients without ARDS

Short-term mortality was reported in 12 studies (8,22-24,26,29,30,32,34-37) (patients n=2,620). The short-term mortality rate was 16.4% (219/1,324) in patients ventilated with a low Vt and 19.5% (254/1,302) in patients ventilated with a high Vt. The meta-analysis revealed no significant difference in short term mortality between patients ventilated with a low Vt and those ventilated with a high Vt (OR, 0.88; 95% CI, 0.71-1.09; P=0.24; Fig. 2). Thus, low Vt alone did not reduce short-term mortality in patients without ARDS. Moreover, there was no evidence of publication bias (Fig. S2), but the overall strength of evidence was low (Table SIII), suggesting that further investigation may influence the estimate.

Primary analysis of the effect of
ventilation with a low or high Vt on short-term mortality in
patients without ARDS. Each square represents the effect size of an
individual study, with the size of the square reflecting the study
weight. Horizontal lines indicate 95%CI. The diamond at the bottom
represents the pooled effect estimate. Vt, tidal volume; ARDS,
acute respiratory distress syndrome; CI, confidence intervals; M-H,
Mantel-Haenszel.

Figure 2

Primary analysis of the effect of ventilation with a low or high Vt on short-term mortality in patients without ARDS. Each square represents the effect size of an individual study, with the size of the square reflecting the study weight. Horizontal lines indicate 95%CI. The diamond at the bottom represents the pooled effect estimate. Vt, tidal volume; ARDS, acute respiratory distress syndrome; CI, confidence intervals; M-H, Mantel-Haenszel.

Low Vt and low Pmax decreases short-term mortality in patients without ARDS

Meta-regression analyses identified Pmax (P=0.01) as a confounding factor in the analysis of short-term mortality (Figs. 3 and S3). Subgroup analysis stratified by Pmax level in patients receiving low Vt ventilation demonstrated that short-term mortality was significantly decreased in those with low Pmax compared with those with high Pmax (OR, 0.50; 95% CI, 0.34-0.75; P=0.0007; Fig. 4). There was no significant difference in short term mortality between patients ventilated with a low Vt and those ventilated with a high Vt in studies with the same or an undefined Pmax (OR, 1.11; 95% CI, 0.86-1.44; P=0.41; Fig. 4). These findings suggested that a low Vt combined with an appropriate Pmax may improve the outcomes of ventilated patients without ARDS.

Meta-regression analysis exploring
Pmax as a potential confounding factor. Pmax, maximum airway
pressure.

Figure 3

Meta-regression analysis exploring Pmax as a potential confounding factor. Pmax, maximum airway pressure.

Subgroup analysis of the effect of
ventilation with a low Vt and a low or high Pmax on short-term
mortality in patients without ARDS. Studies were stratified by Pmax
level (low ≤25 cmH2O vs. high >25 cmH2O).
The pooled odds ratio for each subgroup is shown as a diamond, and
the overall effect across subgroups is also displayed. Vt, tidal
volume; Pmax, maximum airway pressure; ARDS, acute respiratory
distress syndrome; CI, confidence intervals; M-H,
Mantel-Haenszel.

Figure 4

Subgroup analysis of the effect of ventilation with a low Vt and a low or high Pmax on short-term mortality in patients without ARDS. Studies were stratified by Pmax level (low ≤25 cmH2O vs. high >25 cmH2O). The pooled odds ratio for each subgroup is shown as a diamond, and the overall effect across subgroups is also displayed. Vt, tidal volume; Pmax, maximum airway pressure; ARDS, acute respiratory distress syndrome; CI, confidence intervals; M-H, Mantel-Haenszel.

TSA revealed that the diversity-adjusted required information size was 1,876. The cumulative z-curve crossed the trial sequential monitoring boundary for benefit and the conventional boundary for benefit, but did not reach the estimated required information size (Fig. 5). These findings should be interpreted with caution, as the required information size was not reached. Nevertheless, the crossing of the monitoring boundary suggests a potential benefit that warrants confirmation in future larger trials.

Trial sequential analysis plot for
the primary outcome measure (one-sided boundary) of the subgroup
analysis. Minimum desired effect size, 16%; statistical power, 80%;
control event proportion, 33%; measure of diversity, 0%; observed
diversity, 0%.

Figure 5

Trial sequential analysis plot for the primary outcome measure (one-sided boundary) of the subgroup analysis. Minimum desired effect size, 16%; statistical power, 80%; control event proportion, 33%; measure of diversity, 0%; observed diversity, 0%.

Low Vt ventilation decreases the number of days of ventilation, incidence of pulmonary complications and hospital length of stay in patients without ARDS

The number of days of ventilation [mean difference (MD), -1.00; 95% CI, -1.76--0.24; P=0.01; Fig. S4], the incidence of pulmonary complications (studies, n=11; OR, 0.40; 95% CI, 0.30-0.54; P<0.00001; Fig. S5) (24-26,28,29,31-33,35,36,38) and hospital length of stay (studies, n=11; MD, -1.49; 95% CI, -2.54--0.44; P=0.006; Fig. S6) (8,23,24,26,28,29,32-36) were significantly decreased in patients ventilated with a low Vt compared with a high Vt. There was evidence of publication bias among studies reporting the number of days of ventilation.

Discussion

The present systematic review and meta-analysis evaluated the effects of low compared with high Vt ventilation in patients without ARDS. A ventilation strategy combining low Vt with low Pmax was associated with a significant reduction in short-term mortality compared with low Vt combined with high Pmax. Additionally, low Vt ventilation was associated with a reduced duration of ventilation, incidence of pulmonary complications and length of hospital stay compared with high Vt.

The results of the present study demonstrated that low Vt ventilation was not associated with a reduction in short-term mortality in patients without ARDS. Similar to the findings from our previous study (8), the PRoVENT trial reported no significant difference in 28- or 90-day mortality in ICU patients without ARDS who were expected not to be extubated within 24 h of randomization and were ventilated with a low vs. intermediate Vt strategy (39). By contrast, a meta-analysis of 20 articles reported that ventilation with lower Vt was associated with reduced mortality in patients without ARDS (40).

Potentially modifiable factors other than Vt may affect outcomes in patients both with and without ARDS. Decreases in ΔP resulting from changes in ventilator settings have been reported to be strongly associated with increased survival in patients with ARDS (41). ΔP and plateau pressure were risk factors for mortality and ARDS in one cohort study of mechanically ventilated patients without ARDS (11), while ΔP was not associated with hospital mortality in another cohort study of patients without ARDS (42). A secondary analysis of the PRoVENT study reported that a higher Pmax was independently associated with higher in-hospital mortality in critically ill patients under mechanical ventilatory support for reasons other than ARDS (12). Accordingly, in the present meta-analysis, the effects of PEEP, ∆P and Pmax were assessed as confounding factors in short term mortality among ventilated patients without ARDS using meta-regression. Results identified Pmax as a confounding factor and pooled data showed that a ventilation strategy including a low Vt and a low Pmax was associated with a significant reduction in short-term mortality compared with low Vt combined with high Pmax. However, the TSA results should be interpreted with caution, as the required information size was not reached. Nevertheless, the cumulative Z-curve crossed the monitoring boundary for benefit, suggesting a potential survival advantage of low Vt combined with low Pmax that warrants confirmation in future larger trials. Notably, pooled data demonstrated that a ventilation strategy combining low Vt with low Pmax was associated with a significant reduction in short-term mortality compared with low Vt with high Pmax. This finding highlights that limiting both Vt and airway pressure is likely necessary to achieve a survival benefit in patients without ARDS, whereas low Vt alone is insufficient. Ventilation strategies that use a high Vt and a high Pmax may lead to overstretching of alveoli, local production and release of inflammatory mediators, recruitment of neutrophils and ventilator-associated lung injury (1-3).

The findings from the meta-analysis in the present study suggested that duration of ventilation, incidence of pulmonary complications and length of hospital stay may be decreased in patients without ARDS who are ventilated with a low Vt compared with a high Vt. In a post-hoc analysis of a large, randomized trial of low Vt ventilation it was found that during laparoscopic surgeries, low Vt was associated with a markedly reduced pulmonary complications (43). The effect of a low Vt on duration of ventilation is consistent with a previous individual patient data meta-analysis which reported that use of low Vt (≤6 ml/kg of predicted body weight) vs. high Vt (≥10 ml/kg of predicted body weight) in patients without ARDS at the onset of mechanical ventilation was associated with shorter duration of ventilation (6). By contrast, a previously published RCT (8) indicated that a low Vt ventilation strategy was not more effective than an intermediate Vt strategy for decreasing the number of ventilator-free days in patients in the ICU without ARDS. The findings in the present study regarding the effect of a low Vt on the incidence of pulmonary complications and length of hospital stay are consistent with two previous studies (7,40) but contrast with the findings from a third study (8). Consequently, more adequately powered RCTs are needed to evaluate the effect of a low Vt on duration of ventilation, incidence of pulmonary complications and length of hospital stay in patients without ARDS.

Moreover, recent studies support the findings of the present study. For example, one RCT reported that low Vt alone provided no clinical benefit in patients without ARDS (44) and two network meta-analyses both demonstrated that low Vt combined with individualized PEEP reduces pulmonary complications (45,46), which is consistent with the conclusion in the present study that a combination strategy, rather than low Vt alone, is required to improve outcomes.

However, the present meta-analysis has several limitations, including substantial heterogeneity among the included studies; therefore, the results should be interpreted with caution. Specifically, the included studies comprised both ICU-based (11 studies) and intraoperative (seven studies) settings. This mixture may have introduced clinical heterogeneity, as the baseline characteristics, duration of ventilation and severity of illness differ between these two populations. First, data from RCTs and observational studies were pooled; however, the observational studies were of high methodological quality. Second, Pmax varied between studies, and the Pmax setting required for protective mechanical ventilation in patients without ARDS has not been defined. Third, the duration of mechanical ventilation varied across studies. Fourth, Pmax was defined as either peak or plateau pressure across the included studies, and these two variables are physiologically distinct. This heterogeneity in definition may have influenced the results of the Pmax subgroup analysis, and therefore the findings should be interpreted with caution.

In summary, the results of the present study demonstrated that a ventilation strategy combining low Vt with low Pmax was associated with a significant reduction in short-term mortality in patients without ARDS compared with a ventilation strategy combining low Vt with high Pmax. Furthermore, ventilation with a low Vt was associated with a reduced duration of ventilation, incidence of pulmonary complications and length of hospital stay compared with ventilation with a high Vt. Ventilation with a low Vt alone also did not improve short-term mortality. Moreover, the present meta-analysis was limited by heterogeneity between studies.

Supplementary Material

Risk of bias for included randomized control trials. Red (-) indicates a high risk of bias; yellow (?) indicates unclear risk, and green (+) indicates a low risk of bias.
Funnel plot for the effect of low Vt on short-term mortality in patients without ARDS. Vt, tidal volume; ARDS, acute respiratory distress syndrome.
Meta-regression analyses exploring PEEP and ΔP as potential sources of heterogeneity. (A) Meta-regression analyses of PEEP. (B) Meta-regression analyses of ΔP. PEEP, positive endexpiratory pressure; ΔP, driving pressure.
Number of days of ventilation in patients without ARDS. ARDS, acute respiratory distress syndrome.
Incidence of pulmonary complications in patients without ARDS. ARDS, acute respiratory distress syndrome; M-H, Mantel-Haenszel.
Hospital length of stay in patients without ARDS. ARDS, acute respiratory distress syndrome. CI, confidence intervals.
Newcastle-Ottawa quality assessment scale.
Cross-sectional study quality assessment.
GRADE evidence profile for the studies in the meta-analysis.

Acknowledgements

Not applicable.

Funding

Funding: The present work was supported by the National Natural Science Foundation of China (grant no. 81871602).

Availability of data and materials

The data generated in the present study are included in the figures and/or tables of this article.

Authors' contributions

FX and FG conceived and designed the study. ZL, FX and FG developed the methodology. SM assessed the methodological quality and risk of bias of the included studies. MG performed the formal analysis. MG, FX and FG provided resources and curated the data. MG wrote the original draft of the manuscript. All authors reviewed and edited the manuscript. FG supervised the project and acquired the funding. MG and FX confirm the authenticity of all the raw data. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Costa A, Sakho B, Gomez S, Khanyan B, Leybengrub P and Bergese S: Ventilator-associated lung injury: Pathophysiology, prevention, and emerging therapeutic strategies. Int J Mol Sci. 26(10448)2025.PubMed/NCBI View Article : Google Scholar

2 

Acute Respiratory Distress Syndrome Network. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT and Wheeler A: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 342:1301–1308. 2000.PubMed/NCBI View Article : Google Scholar

3 

Merola R, Vargas M and Battaglini D: Ventilator-induced lung injury: The unseen challenge in acute respiratory distress syndrome management. J Clin Med. 14(3910)2025.PubMed/NCBI View Article : Google Scholar

4 

Gajic O, Frutos-Vivar F, Esteban A, Hubmayr RD and Anzueto A: Ventilator settings as a risk factor for acute respiratory distress syndrome in mechanically ventilated patients. Intensive Care Med. 31:922–926. 2005.PubMed/NCBI View Article : Google Scholar

5 

Hager DN, Krishnan JA, Hayden DL and Brower RG: ARDS Clinical Trials Network. Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med. 172:1241–1245. 2005.PubMed/NCBI View Article : Google Scholar

6 

Serpa Neto A, Simonis FD, Barbas CS, Biehl M, Determann RM, Elmer J, Friedman G, Gajic O, Goldstein JN, Horn J, et al: Association between tidal volume size, duration of ventilation, and sedation needs in patients without acute respiratory distress syndrome: An individual patient data meta-analysis. Intensive Care Med. 40:950–957. 2014.PubMed/NCBI View Article : Google Scholar

7 

Neto AS, Simonis FD, Barbas CS, Biehl M, Determann RM, Elmer J, Friedman G, Gajic O, Goldstein JN, Linko R, et al: Lung-protective ventilation with low tidal volumes and the occurrence of pulmonary complications in patients without acute respiratory distress syndrome: A systematic review and individual patient data analysis. Crit Care Med. 43:2155–2163. 2015.PubMed/NCBI View Article : Google Scholar

8 

Writing Group for the PReVENT Investigators. Simonis FD, Serpa Neto A, Binnekade JM, Braber A, Bruin KCM, Determann RM, Goekoop GJ, Heidt J, Horn J, Innemee G, et al: Effect of a low vs intermediate tidal volume strategy on ventilator-free days in intensive care unit patients without ARDS: A randomized clinical trial. JAMA. 320:1872–1880. 2018.PubMed/NCBI View Article : Google Scholar

9 

Schultz MJ, Haitsma JJ, Slutsky AS and Gajic O: What tidal volumes should be used in patients without acute lung injury? Anesthesiology. 106:1226–1231. 2007.PubMed/NCBI

10 

Serpa Neto A, Filho RR, Cherpanath T, Determann R, Dongelmans DA, Paulus F, Tuinman PR, Pelosi P, de Abreu MG and Schultz MJ: PROVE Network Investigators. Associations between positive end-expiratory pressure and outcome of patients without ARDS at onset of ventilation: A systematic review and meta-analysis of randomized controlled trials. Ann Intensive Care. 6(109)2016.PubMed/NCBI View Article : Google Scholar

11 

Fuller BM, Page D, Stephens RJ, Roberts BW, Drewry AM, Ablordeppey E, Mohr NM and Kollef MH: Pulmonary mechanics and mortality in mechanically ventilated patients without acute respiratory distress syndrome: A cohort study. Shock. 49:311–316. 2018.PubMed/NCBI View Article : Google Scholar

12 

Simonis FD, Barbas CSV, Artigas-Raventós A, Canet J, Determann RM, Anstey J, Hedenstierna G, Hemmes SNT, Hermans G, Hiesmayr M, et al: Potentially modifiable respiratory variables contributing to outcome in ICU patients without ARDS: A secondary analysis of PRoVENT. Ann Intensive Care. 8(39)2018.PubMed/NCBI View Article : Google Scholar

13 

Moher D, Liberati A, Tetzlaff J and Altman DG: PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med. 151:264–269, W264. 2009.PubMed/NCBI View Article : Google Scholar

14 

Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA and Thacker SB: Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 283:2008–2012. 2000.PubMed/NCBI View Article : Google Scholar

15 

ARDS Definition Task Force. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L and Slutsky AS: Acute respiratory distress syndrome: The Berlin definition. JAMA. 307:2526–2533. 2012.PubMed/NCBI View Article : Google Scholar

16 

Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L and Sterne JA: Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ. 343(d5928)2011.PubMed/NCBI View Article : Google Scholar

17 

Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 25:603–605. 2010.PubMed/NCBI View Article : Google Scholar

18 

Shamliyan TA, Kane RL, Ansari MT, Raman G, Berkman ND, Grant M, Janes G, Maglione M, Moher D, Nasser M, et al: Development of quality criteria to evaluate nontherapeutic studies of incidence, prevalence, or risk factors of chronic diseases: Pilot study of new checklists [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US): Report No.: 11-EHC008-EF, 2011.

19 

Egger M, Davey Smith G, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:629–634. 1997.PubMed/NCBI View Article : Google Scholar

20 

Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P and Schünemann HJ: GRADE Working Group. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 336:924–926. 2008.PubMed/NCBI View Article : Google Scholar

21 

Pogue JM and Yusuf S: Cumulating evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysis. Control Clin Trials. 18:580–593; discussion 661-6. 1997.PubMed/NCBI View Article : Google Scholar

22 

Determann RM, Royakkers A, Wolthuis EK, Vlaar AP, Choi G, Paulus F, Hofstra JJ, de Graaff MJ, Korevaar JC and Schultz MJ: Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: A preventive randomized controlled trial. Crit Care. 14(R1)2010.PubMed/NCBI View Article : Google Scholar

23 

Fernandez-Bustamante A, Wood CL, Tran ZV and Moine P: Intraoperative ventilation: Incidence and risk factors for receiving large tidal volumes during general anesthesia. BMC Anesthesiol. 11(22)2011.PubMed/NCBI View Article : Google Scholar

24 

Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, Marret E, Beaussier M, Gutton C, Lefrant JY, et al: A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 369:428–437. 2013.PubMed/NCBI View Article : Google Scholar

25 

Ge Y, Yuan L, Jiang X, Wang X, Xu R and Ma W: Effect of lung protection mechanical ventilation on respiratory function in the elderly undergoing spinal fusion. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 38:81–85. 2013.PubMed/NCBI View Article : Google Scholar : (In Chinese).

26 

Kuzkov VV, Rodionova LN, Ilyina YY, Ushakov AA, Sokolova MM, Fot EV, Duberman BL and Kirov MY: Protective ventilation improves gas exchange, reduces incidence of atelectases, and affects metabolic response in major pancreatoduodenal surgery. Front Med (Lausanne). 3(66)2016.PubMed/NCBI View Article : Google Scholar

27 

Lee PC, Helsmoortel CM, Cohn SM and Fink MP: Are low tidal volumes safe? Chest. 97:430–434. 1990.PubMed/NCBI View Article : Google Scholar

28 

Park SJ, Kim BG, Oh AH, Han SH, Han HS and Ryu JH: Effects of intraoperative protective lung ventilation on postoperative pulmonary complications in patients with laparoscopic surgery: Prospective, randomized and controlled trial. Surg Endosc. 30:4598–4606. 2016.PubMed/NCBI View Article : Google Scholar

29 

Pi X, Cui Y, Wang C, Guo L, Sun B, Shi J, Lin Z, Zhao N, Wang W, Fu S and Li E: Low tidal volume with PEEP and recruitment expedite the recovery of pulmonary function. Int J Clin Exp Pathol. 8:14305–14314. 2015.PubMed/NCBI

30 

Pinheiro de Oliveira R, Hetzel MP, dos Anjos Silva M, Dallegrave D and Friedman G: Mechanical ventilation with high tidal volume induces inflammation in patients without lung disease. Crit Care. 14(R39)2010.PubMed/NCBI View Article : Google Scholar

31 

Severgnini P, Selmo G, Lanza C, Chiesa A, Frigerio A, Bacuzzi A, Dionigi G, Novario R, Gregoretti C, de Abreu MG, et al: Protective mechanical ventilation during general anesthesia for open abdominal surgery improves postoperative pulmonary function. Anesthesiology. 118:1307–1321. 2013.PubMed/NCBI View Article : Google Scholar

32 

Shen Zi-Jin and Dong R: Value of protective mechanical ventilation for alleviating symptoms of general anesthesia patients with high risk of postoperative pulmonary complications. J Shanghai Jiaotong University. 35:1632–1636. 2015.

33 

Soh S, Shim JK, Ha Y, Kim YS, Lee H and Kwak YL: Ventilation with high or low tidal volume with PEEP does not influence lung function after spinal surgery in prone position: A randomized controlled trial. J Neurosurg Anesthesiol. 30:237–245. 2018.PubMed/NCBI View Article : Google Scholar

34 

Sundar S, Novack V, Jervis K, Bender SP, Lerner A, Panzica P, Mahmood F, Malhotra A and Talmor D: Influence of low tidal volume ventilation on time to extubation in cardiac surgical patients. Anesthesiology. 114:1102–1110. 2011.PubMed/NCBI View Article : Google Scholar

35 

Treschan TA, Kaisers W, Schaefer MS, Bastin B, Schmalz U, Wania V, Eisenberger CF, Saleh A, Weiss M, Schmitz A, et al: Ventilation with low tidal volumes during upper abdominal surgery does not improve postoperative lung function. Br J Anaesth. 109:263–271. 2012.PubMed/NCBI View Article : Google Scholar

36 

Weingarten TN, Whalen FX, Warner DO, Gajic O, Schears GJ, Snyder MR, Schroeder DR and Sprung J: Comparison of two ventilatory strategies in elderly patients undergoing major abdominal surgery. Br J Anaesth. 104:16–22. 2010.PubMed/NCBI View Article : Google Scholar

37 

Yilmaz M, Keegan MT, Iscimen R, Afessa B, Buck CF, Hubmayr RD and Gajic O: Toward the prevention of acute lung injury: Protocol-guided limitation of large tidal volume ventilation and inappropriate transfusion. Crit Care Med. 35:1660–1666; quiz 1667. 2007.PubMed/NCBI View Article : Google Scholar

38 

Zamani MM, Najafi A, Sehat S, Janforooz Z, Derakhshan P, Rokhtabnak F, Mesbah Kiaee M, Kholdebarin A, Ghorbanlo M, Hemadi MH and Ghodraty MR: The effect of intraoperative lung protective ventilation vs conventional ventilation, on postoperative pulmonary complications after cardiopulmonary bypass. J Cardiovasc Thorac Res. 9:221–228. 2017.PubMed/NCBI View Article : Google Scholar

39 

Neto AS, Barbas CSV, Simonis FD, Artigas-Raventós A, Canet J, Determann RM, Anstey J, Hedenstierna G, Hemmes SNT, Hermans G, et al: Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): An international, multicentre, prospective study. Lancet Respir Med. 4:882–893. 2016.PubMed/NCBI View Article : Google Scholar

40 

Serpa Neto A, Cardoso SO, Manetta JA, Pereira VG, Espósito DC, Pasqualucci Mde O, Damasceno MC and Schultz MJ: Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA. 308:1651–1659. 2012.PubMed/NCBI View Article : Google Scholar

41 

Amato MB, Meade MO, Slutsky AS, Brochard L, Costa EL, Schoenfeld DA, Stewart TE, Briel M, Talmor D, Mercat A, et al: Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 372:747–755. 2015.PubMed/NCBI View Article : Google Scholar

42 

Schmidt MFS, Amaral ACKB, Fan E and Rubenfeld GD: Driving pressure and hospital mortality in patients without ARDS: A cohort study. Chest. 153:46–54. 2018.PubMed/NCBI View Article : Google Scholar

43 

Karalapillai D, Weinberg L, Neto AS, Peyton PJ, Ellard L, Hu R, Pearce B, Tan CO, Story D, O'Donnell M, et al: Low tidal volume ventilation for patients undergoing laparoscopic surgery: A secondary analysis of a randomised clinical trial. BMC Anesthesiol. 23(71)2023.PubMed/NCBI View Article : Google Scholar

44 

Tadié JM, Ouattara A, Laviolle B, Lesouhaitier M, Esvan M, Rousseau C, Grégoire M, Gaudriot B, Nesseler N, Labaste F, et al: Maintaining ventilation with very low tidal volume and positive-end expiratory pressure versus no ventilation during cardiopulmonary bypass for cardiac surgery in adults: A randomized clinical trial. Intensive Care Med. 51:849–860. 2025.PubMed/NCBI View Article : Google Scholar

45 

Mo J, Wang D, Xiao J, Chen Q, An R and Liu HL: Effects of lung protection ventilation strategies on postoperative pulmonary complications after noncardiac surgery: A network meta-analysis of randomized controlled trials. BMC Anesthesiol. 24(346)2024.PubMed/NCBI View Article : Google Scholar

46 

Jivraj NK, Lakbar I, Sadeghirad B, Müller MM, Sohn SY, Peel JK, Jaffer A, Phoophiboon V, Trivedi V, Chaudhuri D, et al: Intra-operative ventilation strategies and their impact on clinical outcomes: A systematic review and network meta-analysis of randomised trials. Anaesthesia. 80:973–987. 2025.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Gu M, Xia F, Lu Z, Meng S and Guo F: Association between tidal volume and mortality in patients&nbsp;without acute respiratory distress syndrome: A systematic review and meta‑analysis. Biomed Rep 25: 98, 2026.
APA
Gu, M., Xia, F., Lu, Z., Meng, S., & Guo, F. (2026). Association between tidal volume and mortality in patients&nbsp;without acute respiratory distress syndrome: A systematic review and meta‑analysis. Biomedical Reports, 25, 98. https://doi.org/10.3892/br.2026.2171
MLA
Gu, M., Xia, F., Lu, Z., Meng, S., Guo, F."Association between tidal volume and mortality in patients&nbsp;without acute respiratory distress syndrome: A systematic review and meta‑analysis". Biomedical Reports 25.2 (2026): 98.
Chicago
Gu, M., Xia, F., Lu, Z., Meng, S., Guo, F."Association between tidal volume and mortality in patients&nbsp;without acute respiratory distress syndrome: A systematic review and meta‑analysis". Biomedical Reports 25, no. 2 (2026): 98. https://doi.org/10.3892/br.2026.2171
Copy and paste a formatted citation
x
Spandidos Publications style
Gu M, Xia F, Lu Z, Meng S and Guo F: Association between tidal volume and mortality in patients&nbsp;without acute respiratory distress syndrome: A systematic review and meta‑analysis. Biomed Rep 25: 98, 2026.
APA
Gu, M., Xia, F., Lu, Z., Meng, S., & Guo, F. (2026). Association between tidal volume and mortality in patients&nbsp;without acute respiratory distress syndrome: A systematic review and meta‑analysis. Biomedical Reports, 25, 98. https://doi.org/10.3892/br.2026.2171
MLA
Gu, M., Xia, F., Lu, Z., Meng, S., Guo, F."Association between tidal volume and mortality in patients&nbsp;without acute respiratory distress syndrome: A systematic review and meta‑analysis". Biomedical Reports 25.2 (2026): 98.
Chicago
Gu, M., Xia, F., Lu, Z., Meng, S., Guo, F."Association between tidal volume and mortality in patients&nbsp;without acute respiratory distress syndrome: A systematic review and meta‑analysis". Biomedical Reports 25, no. 2 (2026): 98. https://doi.org/10.3892/br.2026.2171
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team